Related Experiment Video

Updated: Aug 16, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism

Michelle L Block1, Jau-Shyong Hong

  • 1Neuropharmacology Section, MD F1-01, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709, USA. block@niehs.nih.gov

Progress in Neurobiology
|August 6, 2005
PubMed

Insights

Neuroinflammation driven by microglia activation exacerbates neurodegenerative diseases. This review details how microglia contribute to progressive neuron death in conditions like Alzheimer's and Parkinson's.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Inflammation is a key factor in neurodegenerative diseases.
  • Microglia, the brain's immune cells, release neurotoxic factors when activated.
  • Unregulated microglial activation contributes to neuronal injury.

Purpose of the Study:

  • To review the role of microglial activation in neurodegeneration.
  • To explain the mechanisms by which microglia damage neurons.
  • To describe the cycle of neuron death perpetuated by microglial responses.

Main Methods:

  • Literature review of neuroinflammation and neurodegenerative disease.
  • Analysis of microglial activation pathways.
  • Synthesis of evidence on microglial-neuron interactions.

Main Results:

  • Microglial activation is a common feature across various neurodegenerative conditions.
  • Activated microglia produce inflammatory mediators (e.g., IL-1, TNFalpha, NO) toxic to neurons.
  • Microglial responses to neuronal damage create a self-sustaining cycle of neurodegeneration.

Conclusions:

  • Microglial activation is a critical driver of progressive neurodegeneration.
  • Targeting microglial pathways may offer therapeutic strategies.
  • Understanding the microglial role is essential for combating neurodegenerative diseases.

More Related Videos

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...